Introduction {#H1-1-ZOI190815}
============

Injury is an important cause of death among patients with cancer.^[@zoi190815r1]^ An increased risk of self-inflicted injury, mainly suicide, has been observed among patients with cancer compared with the general population.^[@zoi190815r2],[@zoi190815r3]^ Unintentional injuries, another major category of injury, are the third-leading causes of death in the United States.^[@zoi190815r4]^ There is evidence^[@zoi190815r5],[@zoi190815r6]^ to suggest that suicide and death from unintentional injury share similar risk factors, such as mental distress, physical illnesses, and impaired social and physical functioning caused by treatment. Thus, we believe that it is necessary to examine not only suicide but also death due to unintentional injury among patients with cancer. Few studies^[@zoi190815r7],[@zoi190815r8],[@zoi190815r9]^ have identified increased risk of death from unintentional injury among patients with cancer. Camidge et al^[@zoi190815r7]^ found a relative risk of 1.58 for death from unintentional injury among patients with cancer compared with the general Scottish population. In Japan, Yamauchi et al^[@zoi190815r8]^ reported a relative risk for externally caused injury of 18.8 within the first year after cancer diagnosis. However, no large studies, to our knowledge, have examined the rates of death due to unintentional injury among patients with cancer, and it remains unclear which patient and disease characteristics, such as anatomic site of cancer, are associated with higher rates of death from unintentional injury.

The purpose of our study was to present a comprehensive analysis of death from unintentional injury among patients with cancer using a large population-based cohort. We aimed to assess the incidence of death from unintentional injury among patients with cancer and to identify subgroups of patients with cancer associated with higher rates of death from unintentional injury.

Methods {#H1-2-ZOI190815}
=======

Data Sources {#H2-1-ZOI190815}
------------

This retrospective cohort study included patients diagnosed with a first primary cancer between January 1, 1973, and December 31, 2015, identified from the Surveillance, Epidemiology, and End Results program (SEER) database.^[@zoi190815r10]^ The SEER database provides information on population-based incident tumor statistics from approximately 28% of the US population who reside in various geographic locations of the United States. We used data available for public use from the SEER 18 registries.^[@zoi190815r11]^ To assess comparisons with the general US population, mortality data available from the National Center for Health Statistics^[@zoi190815r11]^ from January 1, 1969, to December 31, 2015, were also collected from the SEER program. The SEER data contain deidentified information and are freely available under a data use agreement with the National Cancer Institute. Thus, this study was considered to be exempt by the institutional review board of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, and informed consent was waived. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology ([STROBE](https://www.equator-network.org/reporting-guidelines/strobe/)) reporting guideline. Analyses were performed from February 1, 2019, to August 15, 2019.

Study Population and Study Variables {#H2-2-ZOI190815}
------------------------------------

Inclusion and exclusion criteria leading to the final cohort of patients with cancer are depicted in the [Figure](#zoi190815f1){ref-type="fig"}. Patients with diagnoses solely from death certificates or autopsy were excluded. Patients were also excluded if their ages at the times of diagnosis and follow-up were unknown. Patients were observed from the time of cancer diagnosis until death due to unintentional injury, death due to other causes, or the end of this study in December 31, 2015, for which we used the SEER vital status variable and the cause-specific death classification variable.

![Flow Diagram of Patient Selection Within the Surveillance, Epidemiology, and End Results (SEER) Database Between 1973 and 2015](jamanetwopen-3-e1921647-g001){#zoi190815f1}

The following variables were examined: age at the time of cancer diagnosis (0-14 years, 15-19 years, 20-39 years, 40-59 years, 60-79 years, and ≥80 years), sex, race/ethnicity (white, black, American Indian or Alaska Native, Asian or Pacific Islander, and unknown), Hispanic origin (Hispanic and non-Hispanic), year of diagnosis (1973-1979, 1980-1989, 1990-1999, 2000-2009, and 2010-2015), marital status at the time of cancer diagnosis (married, unmarried, and unknown), cancer stage (in situ, localized, regional, distant, and unstaged), surgery (yes, no, and unknown), cancer site, and survival time. For stage, we used the SEER summary stage, which defines stage as localized (invasive but confined to the organ of origin), regional (extension beyond the organ of origin but no distant metastasis), or distant (distant metastasis). We did not include radiotherapy and chemotherapy as treatment variables in our analysis because data in the SEER database on radiotherapy and chemotherapy were not sensitive enough and not recommended for use in group comparisons.^[@zoi190815r12]^ For patients who did not survive a full month and whose survival time was recoded as 0 months, the survival time was converted to a one-half month according to standard epidemiologic convention.^[@zoi190815r13]^

Outcome of Interest {#H2-3-ZOI190815}
-------------------

The main outcome of interest was death from unintentional injury among patients with cancer, identified from the following cause of death codes in the SEER database: *International Classification of Diseases, Eighth Revision* codes 800-949; *International Classification of Diseases, Ninth Revision* codes 800-949; and *International Statistical Classification of Diseases and Related Health Problems, Tenth Revision* (*ICD-10*) codes V01-X59 and Y85-Y86 and recode 50210.

Statistical Analysis {#H2-4-ZOI190815}
--------------------

The rates of death from unintentional injury were calculated as the number of deaths from unintentional injury divided by person-years at risk. For site-specific analysis, the mortality rates of each type of cancer were adjusted to the age, sex, race/ethnicity, and calendar year distributions of all patients with a primary cancer. The entire US population with cancer was chosen as the reference category in the adjustment. For a certain type of cancer, the adjusted mortality rate was computed as a weighted average of the stratum-specific mortality rates. The weights for adjustment were the distribution of person-years over the strata of age, sex, race/ethnicity, and calendar year in all patients with a primary cancer. The age and calendar year at diagnosis were used in the adjustment. Given that they were continuous variables, age and calendar year were both divided into 5-year categories. Standardized mortality ratios (SMRs) and 95% CIs were calculated as previously described.^[@zoi190815r2],[@zoi190815r13],[@zoi190815r14]^ In brief, SMRs were estimated as the ratios of observed to expected number of deaths. The observed number of deaths represents the total number of deaths from unintentional injury among patients with cancer recorded during the study period; the expected number of deaths represents the number of individuals who died from unintentional injury in the general population with a similar distribution of age at diagnosis, sex, race/ethnicity, and calendar year. To obtain the expected number of deaths, we derived the stratum-specific mortality rates from unintentional injury of the reference general population collected by the SEER program and calculated the person-years of relevant strata in the cancer group. The stratum-specific expected number of deaths was estimated as the product of mortality rate in the reference group and the person-years in the cancer group. The total expected number of deaths was a summation of all the expected number of deaths across the strata. To identify subgroups associated with a higher incidence of death from unintentional injury, we calculated the rate ratios (RRs) of different groups, which were established as a ratio of the mortality rate of the target group to the reference group. The 95% CI for SMRs and RRs were obtained based on a Poisson regression model.

All statistical tests were 2-sided, and *P* \< .05 was considered to be statistically significant. Analyses were conducted with SEER\*Stat software, version 8.3.5 (US Department of Health and Human Services) and R, version 3.51 (The R Project for Statistical Computing) statistical software.^[@zoi190815r10]^

Results {#H1-3-ZOI190815}
=======

A total of 8 271 020 patients with cancer (50.2% female; mean \[SD\] age, 63.0 \[15.7\] years) observed for 49 571 891 person-years were included, of whom 4 502 302 died after cancer diagnosis. The median follow-up time was 3.6 years (range, 0-42.9 years). The detailed characteristics of the study participants are shown in [Table 1](#zoi190815t1){ref-type="table"}. Unintentional injury was the cause of death in 40 599 of these patients. Among all patients with a first primary cancer, the rate of death from unintentional injury was 81.90 per 100 000 person-years. In contrast, the corresponding rate of death from unintentional injury in the US general population was 51.21 per 100 000 person-years (SMR, 1.60; 95% CI, 1.58-1.61).

###### Death From Unintentional Injury Among Patients With Cancer by Demographic and Tumor Characteristics

  Characteristic                                             Patients With Cancer, No. (%)   Person-Years of Follow-up   Death From Unintentional Injury   SMR (95% CI)[^b^](#zoi190815t1n2){ref-type="table-fn"}   RR (95% CI)[^c^](#zoi190815t1n3){ref-type="table-fn"}   *P* Value                                         
  ---------------------------------------------------------- ------------------------------- --------------------------- --------------------------------- -------------------------------------------------------- ------------------------------------------------------- ----------- ------------------ ------------------ --------
  Overall                                                    8 271 020 (100)                 49 571 891                  40 599 (100)                      81.90                                                    25 385.6                                                51.21       1.60 (1.58-1.61)   NA                 NA
  Age at diagnosis, y                                                                                                                                                                                                                                                                                                         
  0-14                                                       70 918 (0.9)                    670 265                     172 (0.4)                         25.66                                                    87.0                                                    12.98       1.98 (1.70-2.30)   0.26 (0.23-0.31)   \<.001
  15-19                                                      35 104 (0.4)                    350 832                     143 (0.4)                         40.76                                                    133.7                                                   38.11       1.07 (0.91-1.26)   0.42 (0.36-0.49)   \<.001
  20-39                                                      509 320 (6.2)                   4 965 279                   1836 (4.5)                        36.98                                                    1535.3                                                  30.92       1.20 (1.14-1.25)   0.38 (0.36-0.40)   \<.001
  40-59                                                      2 468 035 (29.8)                18 374 139                  8182 (20.2)                       44.53                                                    5976.5                                                  32.53       1.37 (1.34-1.40)   0.46 (0.45-0.47)   \<.001
  60-79                                                      4 055 038 (49.0)                22 101 157                  21 475 (52.9)                     97.17                                                    11 468.2                                                51.89       1.87 (1.85-1.90)   1 \[Reference\]    NA
  ≥80                                                        1 132 605 (13.7)                3 110 219                   8791 (21.7)                       282.65                                                   6184.9                                                  198.86      1.42 (1.39-1.45)   2.91 (2.84-2.98)   \<.001
  Sex                                                                                                                                                                                                                                                                                                                         
  Female                                                     4 154 399 (50.2)                27 009 545                  16 818 (41.4)                     62.27                                                    9276.4                                                  34.34       1.81 (1.79-1.84)   1 \[Reference\]    NA
  Male                                                       4 116 621 (49.8)                22 562 346                  23 781 (58.6)                     105.40                                                   16 109.3                                                71.40       1.48 (1.46-1.50)   1.69 (1.66-1.73)   \<.001
  Race/ethnicity[^d^](#zoi190815t1n4){ref-type="table-fn"}                                                                                                                                                                                                                                                                    
  White                                                      5 740 618 (69.4)                32 171 107                  26 929 (66.3)                     83.71                                                    17 131.9                                                53.25       1.57 (1.55-1.59)   1 \[Reference\]    NA
  Black                                                      723 872 (8.8)                   3 462 970                   2540 (6.3)                        73.35                                                    1893.6                                                  54.68       1.34 (1.29-1.39)   0.88 (0.84-0.91)   \<.001
  American Indian or Alaska Native                           37 945 (0.5)                    188 551                     233 (0.6)                         123.57                                                   116.9                                                   62.00       1.99 (1.75-2.27)   1.48 (1.30-1.68)   \<.001
  Asian or Pacific Islander                                  452 926 (5.5)                   2 405 246                   1310 (3.2)                        54.46                                                    677.1                                                   28.15       1.93 (1.83-2.04)   0.65 (0.62-0.69)   \<.001
  Unknown                                                    96 963 (1.2)                    486 437                     97 (0.2)                          19.94                                                    NA                                                      NA          NA                 NA                 NA
  Hispanic origin                                                                                                                                                                                                                                                                                                             
  Non-Hispanic                                               7 584 447 (91.7)                46 005 352                  38 450 (94.7)                     83.58                                                    23 758.5                                                51.64       1.62 (1.60-1.63)   1 \[Reference\]    NA
  Hispanic                                                   686 573 (8.3)                   3 566 539                   2149 (5.3)                        60.25                                                    1627.2                                                  45.62       1.32 (1.27-1.38)   0.72 (0.69-0.75)   \<.001
  Year of diagnosis                                                                                                                                                                                                                                                                                                           
  1973-1979                                                  427 455 (5.2)                   3 809 616                   3180 (7.8)                        83.47                                                    1995.5                                                  52.38       1.59 (1.54-1.65)   1.09 (1.05-1.13)   \<.001
  1980-1989                                                  791 241 (9.6)                   7 047 964                   6310 (15.5)                       89.53                                                    3304.0                                                  46.88       1.91 (1.86-1.96)   1.17 (1.13-1.20)   \<.001
  1990-1999                                                  1 327 978 (16.1)                11 931 280                  9781 (24.1)                       81.98                                                    5512.0                                                  46.20       1.77 (1.74-1.81)   1.07 (1.04-1.09)   \<.001
  2000-2009                                                  3 444 331 (41.6)                21 897 895                  16 816 (41.4)                     76.79                                                    11 523.1                                                52.62       1.46 (1.44-1.48)   1 \[Reference\]    NA
  2010-2015                                                  2 280 015 (27.6)                4 885 135                   4512 (11.1)                       92.36                                                    3051.0                                                  62.46       1.48 (1.44-1.52)   1.20 (1.16-1.24)   \<.001
  Marital status                                                                                                                                                                                                                                                                                                              
  Married                                                    4 563 510 (55.2)                30 318 658                  21 370 (52.6)                     70.48                                                    14 863.1                                                49.02       1.44 (1.42-1.46)   1 \[Reference\]    NA
  Unmarried                                                  3 089 379 (37.4)                3 625 370                   16 088 (39.6)                     86.64                                                    8464.4                                                  56.77       1.90 (1.87-1.93)   1.23 (1.18-1.28)   \<.001
  Unknown                                                    618 131 (7.5)                   15 627 863                  3141 (7.7)                        102.94                                                   2058.1                                                  54.16       1.53 (1.47-1.58)   1.46 (1.43-1.49)   \<.001
  Cancer stage                                                                                                                                                                                                                                                                                                                
  In situ                                                    505 512 (6.1)                   4 375 845                   2462 (6.1)                        56.26                                                    1746.2                                                  39.90       1.41 (1.36-1.47)   0.78 (0.75-0.82)   \<.001
  Localized                                                  3 210 553 (38.8)                26 054 162                  18 728 (46.1)                     71.88                                                    13 325.8                                                51.15       1.41 (1.39-1.43)   1 \[Reference\]    NA
  Regional                                                   1 412 579 (17.1)                7 997 811                   6431 (15.8)                       80.41                                                    3653.6                                                  45.68       1.76 (1.72-1.80)   1.12 (1.09-1.15)   \<.001
  Distant                                                    1 481 379 (17.9)                3 156 920                   3745 (9.2)                        118.63                                                   1658.5                                                  52.54       2.26 (2.19-2.33)   1.65 (1.59-1.71)   \<.001
  Unstaged                                                   1 660 997 (20.1)                7 987 153                   9233 (22.7)                       115.60                                                   5001.5                                                  62.62       1.85 (1.81-1.88)   1.61 (1.57-1.65)   \<.001
  Surgery                                                                                                                                                                                                                                                                                                                     
  Yes                                                        4 947 428 (59.8)                38 199 670                  26 245 (64.6)                     68.70                                                    17 777.1                                                46.54       1.48 (1.46-1.49)   1 \[Reference\]    NA
  No                                                         3 187 762 (38.5)                10 868 054                  13 765 (33.9)                     126.66                                                   7306.1                                                  67.23       1.88 (1.85-1.92)   1.84 (1.81-1.88)   \<.001
  Unknown                                                    135 830 (1.6)                   504 167                     589 (1.5)                         116.83                                                   302.4                                                   59.98       1.95 (1.80-2.11)   1.70 (1.57-1.85)   \<.001

Abbreviations: NA, not applicable; RR, rate ratio; SMR, standardized mortality ratio.

Observed deaths represent the total number of deaths from unintentional injury among patients with cancer recorded during the study period. Expected deaths represent the number of individuals who died of unintentional injury in the general population with a similar distribution of age at diagnosis (5-year intervals), sex, race/ethnicity (white, black, and other), and calendar year of diagnosis (5-year intervals).

Estimated as the ratios of observed to expected number of deaths. For the categories of age, sex, and year of diagnosis, the SMR reference population was the specific category in the US subpopulation from 1973 through 2015. For race/ethnicity, the specific race/ethnicity codes (white, black, American Indian or Alaska Native, and Asian or Pacific Islander) were used.

Rate ratios were calculated as the ratios of the crude mortality rate in a certain group to that in the reference group.

For race, patients diagnosed before 1990 were excluded because the Surveillance, Epidemiology, and End Results program began to report data regarding ethnicity in 1990.

Patient Characteristics {#H2-5-ZOI190815}
-----------------------

Higher rates of death from unintentional injury among patients with cancer were associated with increasing age at diagnosis (\>80 years; RR, 2.91; 95% CI, 2.84-2.98; *P* \< .001), male sex (RR, 1.69; 95% CI, 1.66-1.73; *P* \< .001), American Indian or Alaska Native population (RR, 1.48; 95% CI, 1.30-1.68; *P* \< .001), non-Hispanic origin (RR, 1.39; 95% CI, 1.33-1.45; *P* \< .001), and being unmarried (RR, 1.23; 95% CI, 1.18-1.28; *P* \< .001) ([Table 1](#zoi190815t1){ref-type="table"}). Although only 3745 patients (9.2%) had advanced disease, the highest rate of death from unintentional injury was among these patients (118.63 per 100 000 person-years). Rates of death from unintentional injury were higher among patients diagnosed before 1990, decreased gradually thereafter, and increased again among patients diagnosed from 2010 to 2015.

Tumor Sites {#H2-6-ZOI190815}
-----------

For 28 of 29 cancer sites (all except the testis), rates of death from unintentional injury were higher among patients with cancer than in the general population ([Table 2](#zoi190815t2){ref-type="table"}). After adjustment for age at diagnosis, race/ethnicity, sex, and calendar year, rates of death from unintentional injury were the highest among patients with liver cancer (200.37 per 100 000 person-years; SMR, 4.09; 95% CI, 3.68-4.54), followed by brain cancer (175.04 per 100 000 person-years; SMR, 2.41; 95% CI, 2.18-2.68), laryngeal cancer (148.78 per 100 000 person-years; SMR, 2.27; 95% CI, 2.10-2.46), and esophagus cancer (144.98 per 100 000 person-years; SMR, 2.52; 95% CI, 2.20-2.88). Compared with the general population, the highest risk of death from unintentional injury was observed among patients with liver cancer (RR, 2.10; 95% CI, 1.86-2.37; *P* \< .001).

###### Death From Unintentional Injury by Anatomic Site of Cancer[^a^](#zoi190815t2n1){ref-type="table-fn"}

  Anatomic Site                                   Patients With Cancer, No.   Survival Time, Person-Years   Observed Deaths in Patients With Cancer, No. (%)[^b^](#zoi190815t2n2){ref-type="table-fn"}   Mortality Rate, per 100 000 Person-Years[^c^](#zoi190815t2n3){ref-type="table-fn"}   Expected Deaths in General Population[^d^](#zoi190815t2n4){ref-type="table-fn"}^,^[^e^](#zoi190815t2n5){ref-type="table-fn"}   SMR (95% CI)[^e^](#zoi190815t2n5){ref-type="table-fn"}^,^[^f^](#zoi190815t2n6){ref-type="table-fn"}   Rate Ratio (95% CI)[^g^](#zoi190815t2n7){ref-type="table-fn"}   *P* Value
  ----------------------------------------------- --------------------------- ----------------------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------- --------------------------------------------------------------- -----------
  Liver                                           110 062                     151 540                       347                                                                                          200.37                                                                               84.8                                                                                                                           4.09 (3.68-4.54)                                                                                      2.10 (1.86-2.37)                                                \<.001
  Brain                                           119 951                     433 152                       360                                                                                          175.04                                                                               149.1                                                                                                                          2.41 (2.18-2.68)                                                                                      1.87 (1.72-2.03)                                                \<.001
  Larynx                                          68 477                      448 253                       626                                                                                          148.78                                                                               275.5                                                                                                                          2.27 (2.10-2.46)                                                                                      1.56 (1.43-1.71)                                                \<.001
  Esophagus                                       71 098                      128 516                       216                                                                                          144.98                                                                               85.8                                                                                                                           2.52 (2.20-2.88)                                                                                      1.52 (1.31-1.77)                                                \<.001
  Myeloma                                         97 618                      328 220                       464                                                                                          130.25                                                                               202.4                                                                                                                          2.29 (2.09-2.51)                                                                                      1.37 (1.23-1.52)                                                \<.001
  Lung and bronchus                               941 791                     1 736 764                     2516                                                                                         128.60                                                                               1023.9                                                                                                                         2.46 (2.36-2.56)                                                                                      1.35 (1.27-1.43)                                                \<.001
  Leukemia                                        214 713                     1 027 293                     1132                                                                                         123.22                                                                               521.3                                                                                                                          2.17 (2.05-2.30)                                                                                      1.31 (1.22-1.41)                                                \<.001
  Oral cavity and pharynx                         188 740                     1 078 200                     1363                                                                                         121.79                                                                               596.5                                                                                                                          2.28 (2.17-2.41)                                                                                      1.28 (1.19-1.37)                                                \<.001
  Pancreas                                        188 750                     170 723                       247                                                                                          121.64                                                                               109.3                                                                                                                          2.26 (2.00-2.56)                                                                                      1.28 (1.11-1.47)                                                \<.001
  Small intestine                                 27 886                      134 104                       140                                                                                          115.33                                                                               72.1                                                                                                                           1.94 (1.65-2.29)                                                                                      1.21 (1.03-1.43)                                                .01
  Stomach                                         136 907                     348 706                       441                                                                                          112.60                                                                               230.9                                                                                                                          1.91 (1.74-2.10)                                                                                      1.18 (1.06-1.32)                                                .001
  Anus, anal canal, and anorectum                 33 161                      193 730                       176                                                                                          104.43                                                                               91.9                                                                                                                           1.92 (1.65-2.22)                                                                                      1.10 (0.95-1.27)                                                .11
  Kidney and renal pelvis                         205 813                     1 127 572                     1071                                                                                         94.52                                                                                621.0                                                                                                                          1.72 (1.62-1.83)                                                                                      0.99 (0.92-1.07)                                                .42
  Lymphoma                                        355 580                     2 222 105                     1812                                                                                         93.84                                                                                1107.3                                                                                                                         1.64 (1.56-1.71)                                                                                      1 \[Reference\]                                                 NA
  Eye and orbit                                   14 345                      110 083                       90                                                                                           92.11                                                                                61.3                                                                                                                           1.47 (1.19-1.80)                                                                                      0.97 (0.79-1.18)                                                .37
  Bones and joints                                16 369                      125 761                       84                                                                                           89.41                                                                                46.0                                                                                                                           1.83 (1.47-2.26)                                                                                      0.95 (0.79-1.15)                                                .31
  Breast                                          1 343 540                   11 458 385                    5968                                                                                         86.12                                                                                3746.4                                                                                                                         1.59 (1.55-1.63)                                                                                      0.90 (0.86-0.95)                                                \<.001
  Other nervous system including cranial nerves   110 098                     505 274                       495                                                                                          80.66                                                                                276.9                                                                                                                          1.79 (1.64-1.95)                                                                                      0.85 (0.76-0.94)                                                .001
  Soft tissue including heart                     50 345                      339 247                       215                                                                                          80.40                                                                                156.88                                                                                                                         137 (1.20-1.57)                                                                                       0.86 (0.76-0.97)                                                .01
  Urinary bladder                                 304 521                     2 053 140                     2248                                                                                         80.20                                                                                1515.6                                                                                                                         1.48 (1.42-1.55)                                                                                      0.84 (0.79-0.90)                                                \<.001
  Colon and rectum                                824 153                     4 936 424                     4911                                                                                         79.66                                                                                3120.5                                                                                                                         1.57 (1.53-1.62)                                                                                      0.84 (0.79-0.88)                                                \<.001
  Endocrine system                                220 146                     1 729 526                     651                                                                                          78.26                                                                                559.6                                                                                                                          1.16 (1.08-1.26)                                                                                      0.82 (0.77-0.88)                                                \<.001
  Skin, non-basal                                 491 679                     3 962 943                     2242                                                                                         70.37                                                                                1986.5                                                                                                                         1.13 (1.08-1.18)                                                                                      0.74 (0.70-0.78)                                                \<.001
  Vulva                                           48 147                      421 438                       309                                                                                          44.68                                                                                126.9                                                                                                                          2.43 (2.18-2.72)                                                                                      0.47 (0.40-0.54)                                                \<.001
  Prostate                                        1 137 848                   8 625 118                     8365                                                                                         39.68                                                                                6424.8                                                                                                                         1.30 (1.27-1.33)                                                                                      0.42 (0.39-0.44)                                                \<.001
  Cervix uteri                                    87 245                      771 211                       331                                                                                          37.66                                                                                171.8                                                                                                                          1.93 (1.73-2.15)                                                                                      0.40 (0.35-0.45)                                                \<.001
  Testis                                          52 616                      606 739                       315                                                                                          36.51                                                                                344.2                                                                                                                          0.92 (0.82-1.02)                                                                                      0.39 (0.34-0.45)                                                \<.001
  Ovary                                           128 056                     712 331                       322                                                                                          29.58                                                                                198.3                                                                                                                          1.62 (1.46-1.81)                                                                                      0.31 (0.27-0.36)                                                \<.001
  Corpus and uterus, not otherwise specified      245 483                     2 183 171                     1195                                                                                         29.00                                                                                673.4                                                                                                                          1.77 (1.68-1.88)                                                                                      0.30 (0.28-0.33)                                                \<.001

Abbreviation: SMR, standardized mortality ratio.

Analysis was limited to tumor sites at least 100 000 person-years. For adult-onset cancers, mortality rates and SMRs were calculated in patients with cancer aged 20 years or older; for cancers of brain, leukemias, lymphomas, cancers of bone and joint, cancers of soft tissue, and cancers of testis, mortality rates were calculated in all ages.

The total number of deaths from unintentional injury in patients with cancer recorded during the study period.

Adjusted to the age at diagnosis, race, sex, and calendar year of diagnosis distributions of all patients with the first primary tumor.

The number of individuals who died of unintentional injury in the general population with a similar distribution of age at diagnosis (5-year intervals), sex, race/ethnicity (white, black, and other), and calendar year of diagnosis (5-year age intervals).

Reference population is defined as the general US population, 1973 to 2015.

Estimated as the ratios of observed to expected number of deaths.

Calculated as the ratios of the mortality rates from unintentional injury in patients with a certain cancer to that in patients with lymphoma.

Risk of Death {#H2-7-ZOI190815}
-------------

For most cancer types, the SMRs of death from unintentional injury were the highest in the first month after cancer diagnosis, decreased gradually from 1 month to 5 years, and increased after 5 years ([Table 3](#zoi190815t3){ref-type="table"}). For certain cancers (eg, breast, prostate, skin, urinary bladder, vulva, and corpus uteri), the SMRs of death from unintentional injury were higher during the 5 years after diagnosis than within the first month.

###### Death From Unintentional Injury Among Patients With Cancer by Site and Time Since Diagnosis[^a^](#zoi190815t3n1){ref-type="table-fn"}

  Cancer Site, Time Since Diagnosis                Person-Years Accrued[^b^](#zoi190815t3n2){ref-type="table-fn"}   Deaths From Unintentional Injury, No./Total No. (%)   SMR (95% CI)[^c^](#zoi190815t3n3){ref-type="table-fn"}
  ------------------------------------------------ ---------------------------------------------------------------- ----------------------------------------------------- --------------------------------------------------------
  **All**                                                                                                                                                                 
  Within 1 mo                                      669 147                                                          1489/40 599 (3.7)                                     3.21 (3.05-3.38)
  2-12 mo                                          5 607 093                                                        5218/40 599 (12.9)                                    1.45 (1.41-1.49)
  13 mo to 5 y                                     18 349 230                                                       12 421/40 599 (30.6)                                  1.18 (1.16-1.20)
  \>5 y                                            24 959 086                                                       21 471/40 599 (52.9)                                  1.99 (1.97-2.02)
  **Liver**                                                                                                                                                               
  Within 1 mo                                      8314                                                             54/347 (15.6)                                         9.18 (7.03-11.99)
  2-12 mo                                          44 702                                                           121/347 (34.9)                                        4.26 (3.56-5.09)
  13 mo to 5 y                                     68 233                                                           138/347 (39.8)                                        3.66 (3.10-4.32)
  \>5 y                                            30 812                                                           34/347 (9.8)                                          2.57 (1.83-3.59)
  **Brain**                                                                                                                                                               
  Within 1 mo                                      9602                                                             22/360 (6.1)                                          4.29 (2.82-6.51)
  2-12 mo                                          68 347                                                           73/360 (20.3)                                         2.48 (1.97-3.12)
  13 mo to 5 y                                     157 163                                                          119/360 (33.1)                                        2.16 (1.81-2.59)
  \>5 y                                            198 350                                                          146/360 (40.6)                                        2.44 (2.08-2.87)
  **Larynx**                                                                                                                                                              
  Within 1 mo                                      5646                                                             7/626 (1.1)                                           1.71 (0.82-3.60)
  2-12 mo                                          50 870                                                           85/626 (13.6)                                         2.38 (1.93-2.95)
  13 mo to 5 y                                     166 274                                                          207/626 (33.1)                                        1.88 (1.64-2.16)
  \>5 y                                            225 513                                                          327/626 (52.2)                                        2.60 (2.33-2.89)
  **Esophagus**                                                                                                                                                           
  Within 1 mo                                      5663                                                             19/216 (8.8)                                          4.02 (2.57-6.31)
  2-12 mo                                          35 730                                                           68/216 (31.5)                                         2.49 (1.96-3.16)
  13 mo to 5 y                                     52 573                                                           71/216 (32.9)                                         2.01 (1.59-2.54)
  \>5 y                                            34 779                                                           58/216 (26.9)                                         3.11 (2.40-4.02)
  **Myeloma**                                                                                                                                                             
  Within 1 mo                                      7874                                                             40/464 (8.6)                                          6.38 (4.68-8.69)
  2-12 mo                                          63 854                                                           95/464 (20.5)                                         2.04 (1.67-2.49)
  13 mo to 5 y                                     166 638                                                          209/464 (45.0)                                        1.98 (1.73-2.26)
  \>5 y                                            90 031                                                           120/464 (25.9)                                        2.72 (2.28-3.26)
  **Lung and Bronchus**                                                                                                                                                   
  Within 1 mo                                      73 393                                                           291/2516 (11.6)                                       5.18 (4.62-5.81)
  2-12 mo                                          444 261                                                          768/2516 (30.5)                                       2.51 (2.34-2.69)
  13 mo to 5 y                                     705 835                                                          790/2516 (31.4)                                       1.86 (1.73-1.99)
  \>5 y                                            516 886                                                          667/2516 (26.5)                                       2.78 (2.58-3.00)
  **Leukemia**                                                                                                                                                            
  Within 1 mo                                      16 894                                                           109/1132 (9.6)                                        8.54 (7.08-10.30)
  2-12 mo                                          132 969                                                          247/1132 (21.8)                                       2.78 (2.46-3.15)
  13 mo to 5 y                                     402 700                                                          418/1132 (36.9)                                       1.80 (1.63-1.98)
  \>5 y                                            475 156                                                          358/1132 (31.6)                                       1.91 (1.72-2.11)
  **Oral Cavity and Pharynx**                                                                                                                                             
  Within 1 mo                                      15 538                                                           22/1363 (1.6)                                         2.03 (1.34-3.09)
  2-12 mo                                          135 986                                                          204/1363 (15.0)                                       2.26 (1.97-2.59)
  13 mo to 5 y                                     409 425                                                          492/1363 (36.1)                                       2.00 (1.83-2.18)
  \>5 y                                            517 422                                                          645/1363 (47.3)                                       2.59 (2.40-2.80)
  **Pancreas**                                                                                                                                                            
  Within 1 mo                                      14 241                                                           33/247 (13.4)                                         2.72 (1.93-3.82)
  2-12 mo                                          65 797                                                           115/247 (46.6)                                        2.45 (2.04-2.94)
  13 mo to 5 y                                     60 994                                                           61/247 (24.7)                                         1.66 (1.29-2.13)
  \>5 y                                            30 738                                                           38/247 (15.4)                                         2.64 (1.92-3.63)
  **Small Intestine**                                                                                                                                                     
  Within 1 mo                                      2245                                                             12/140 (8.6)                                          7.69 (4.36-13.53)
  2-12 mo                                          18 529                                                           25/140 (17.9)                                         2.12 (1.43-3.13)
  13 mo to 5 y                                     56 640                                                           37/140 (26.4)                                         1.13 (0.82-1.56)
  \>5 y                                            56 737                                                           66/140 (47.1)                                         2.53 (1.99-3.22)
  **Stomach**                                                                                                                                                             
  Within 1 mo                                      10 778                                                           28/441 (6.3)                                          2.96 (2.04-4.29)
  2-12 mo                                          69 902                                                           111/441 (25.2)                                        2.02 (1.68-2.43)
  13 mo to 5 y                                     136 959                                                          135/441 (30.6)                                        1.41 (1.19-1.67)
  \>5 y                                            131 547                                                          167/441 (37.9)                                        2.34 (2.01-2.72)
  **Anus, Anal Canal, and Anorectum**                                                                                                                                     
  Within 1 mo                                      2735                                                             3/176 (1.7)                                           1.89 (0.61-5.85)
  2-12 mo                                          24 695                                                           28/176 (15.9)                                         2.05 (1.41-2.96)
  13 mo to 5 y                                     80 373                                                           56/176 (31.8)                                         1.37 (1.06-1.78)
  \>5 y                                            85 949                                                           89/176 (50.6)                                         2.48 (2.02-3.06)
  **Lymphoma**                                                                                                                                                            
  Within 1 mo                                      28 771                                                           76/1812 (4.2)                                         3.84 (3.07-4.81)
  2-12 mo                                          243 083                                                          320/1812 (17.7)                                       2.10 (1.88-2.34)
  13 mo to 5 y                                     813 535                                                          533/1812 (29.4)                                       1.19 (1.09-1.29)
  \>5 y                                            1 137 212                                                        883/1812 (48.7)                                       1.81 (1.70-1.94)
  **Kidney and Renal Pelvis**                                                                                                                                             
  Within 1 mo                                      16 756                                                           54/1071 (5.0)                                         4.70 (3.60-6.14)
  2-12 mo                                          141 313                                                          152/1071 (14.2)                                       1.67 (1.42-1.95)
  13 mo to 5 y                                     457 695                                                          336/1071 (31.4)                                       1.24 (1.11-1.38)
  \>5 y                                            512 104                                                          529/1071 (49.4)                                       2.14 (1.96-2.33)
  **Eye and Orbit**                                                                                                                                                       
  Within 1 mo                                      1185                                                             0/90                                                  NA
  2-12 mo                                          11 165                                                           6/90 (6.7)                                            0.77 (0.35-1.72)
  13 mo to 5 y                                     40 228                                                           40/90 (44.4)                                          1.57 (1.15-2.14)
  \>5 y                                            57 510                                                           44/90 (48.9)                                          1.61 (1.20-2.17)
  **Bones and Joints**                                                                                                                                                    
  Within 1 mo                                      1348                                                             1/84 (1.2)                                            1.65 (0.23-11.71)
  2-12 mo                                          12 142                                                           11/84 (13.1)                                          2.19 (1.22-3.96)
  13 mo to 5 y                                     39 674                                                           25/84 (29.8)                                          1.68 (1.14-2.49)
  \>5 y                                            72 609                                                           47/84 (56.0)                                          1.84 (1.38-2.45)
  **Breast**                                                                                                                                                              
  Within 1 mo                                      111 241                                                          62/5968 (1.0)                                         1.32 (1.03-1.69)
  2-12 mo                                          1 055 680                                                        382/5968 (6.4)                                        0.88 (0.79-0.97)
  13 mo to 5 y                                     4 024 018                                                        1621/5968 (27.2)                                      1.06 (1.01-1.12)
  \>5 y                                            6 267 956                                                        3903/5968 (65.4)                                      2.24 (2.17-2.31)
  **Soft Tissue Including Heart**                                                                                                                                         
  Within 1 mo                                      3634                                                             6/215 (2.8)                                           2.43 (1.09-5.41)
  2-12 mo                                          35 833                                                           23/215 (10.7)                                         1.10 (0.73-1.66)
  13 mo to 5 y                                     114 900                                                          64/215 (29.8)                                         1.08 (0.84-1.38)
  \>5 y                                            184 450                                                          122/215 (56.7)                                        1.65 (1.38-1.96)
  **Cranial Nerves and Other Nervous System**                                                                                                                             
  Within 1 mo                                      8992                                                             79/495 (16.0)                                         12.73 (10.21-15.88)
  2-12 mo                                          80 202                                                           103/495 (20.8)                                        1.97 (1.63-2.40)
  13 mo to 5 y                                     263 499                                                          190/495 (38.4)                                        1.26 (1.09-1.45)
  \>5 y                                            152 676                                                          123/495 (24.8)                                        1.82 (1.53-2.18)
  **Urinary Bladder**                                                                                                                                                     
  Within 1 mo                                      25 049                                                           38/2248 (1.7)                                         1.50 (1.10-2.07)
  2-12 mo                                          224 684                                                          217/2248 (9.7)                                        1.01 (0.88-1.15)
  13 mo to 5 y                                     768 511                                                          699/2248 (31.1)                                       1.07 (1.00-1.16)
  \>5 y                                            1 035 143                                                        1294/2248 (57.6)                                      2.07 (1.96-2.19)
  **Colon and Rectum**                                                                                                                                                    
  Within 1 mo                                      66 791                                                           145/4911 (3.0)                                        2.60 (2.21-3.06)
  2-12 mo                                          572 266                                                          546/4911 (11.1)                                       1.23 (1.13-1.33)
  13 mo to 5 y                                     1 850 609                                                        1407/4911 (28.6)                                      1.07 (1.02-1.13)
  \>5 y                                            2 447 885                                                        2813/4911 (57.3)                                      2.15 (2.07-2.23)
  **Endocrine System**                                                                                                                                                    
  Within 1 mo                                      18 139                                                           19/651 (2.9)                                          2.69 (1.71-4.21)
  2-12 mo                                          168 187                                                          66/651 (10.1)                                         1.04 (0.82-1.32)
  13 mo to 5 y                                     626 797                                                          203/651 (31.2)                                        0.91 (0.80-1.05)
  \>5 y                                            916 527                                                          363/651 (55.8)                                        1.36 (1.23-1.51)
  **Skin Excluding Basal and Squamous Cell**                                                                                                                              
  Within 1 mo                                      40 323                                                           23/2242 (1.0)                                         0.86 (0.57-1.29)
  2-12 mo                                          375 788                                                          186/2242 (8.3)                                        0.76 (0.66-0.88)
  13 mo to 5 y                                     1 404 571                                                        729/2242 (32.5)                                       0.89 (0.83-0.96)
  \>5 y                                            2 142 504                                                        1304/2242 (58.2)                                      1.45 (1.37-1.53)
  **Vulva**                                                                                                                                                               
  Within 1 mo                                      3972                                                             0/309                                                 NA
  2-12 mo                                          37 053                                                           22/309 (7.1)                                          1.39 (0.91-2.11)
  13 mo to 5 y                                     141 123                                                          88/309 (28.5)                                         1.74 (1.42-2.15)
  \>5 y                                            239 313                                                          199/309 (64.4)                                        3.38 (2.94-3.89)
  **Prostate**                                                                                                                                                            
  Within 1 mo                                      94 085                                                           103/8365 (1.2)                                        1.25 (1.03-1.52)
  2-12 mo                                          895 132                                                          590/8365 (7.1)                                        0.77 (0.71-0.84)
  13 mo to 5 y                                     3 459 819                                                        2632/8365 (31.5)                                      0.95 (0.92-0.99)
  \>5 y                                            4 176 472                                                        5040/8365 (60.3)                                      1.79 (1.74-1.84)
  **Cervix Uteri**                                                                                                                                                        
  Within 1 mo                                      7188                                                             5/331 (1.5)                                           2.29 (0.95-5.50)
  2-12 mo                                          64 728                                                           38/331 (11.5)                                         2.07 (1.51-2.85)
  13 mo to 5 y                                     220 423                                                          75/331 (22.7)                                         1.36 (1.09-1.71)
  \>5 y                                            478 937                                                          213/331 (64.4)                                        2.21 (1.93-2.53)
  **Testis**                                                                                                                                                              
  Within 1 mo                                      4346                                                             0/315                                                 NA
  2-12 mo                                          41 231                                                           47/315 (14.9)                                         2.03 (1.53-2.71)
  13 mo to 5 y                                     166 366                                                          80/315 (25.4)                                         0.86 (0.69-1.08)
  \>5 y                                            394 814                                                          188/315 (59.7)                                        0.83 (0.72-0.96)
  **Ovary**                                                                                                                                                               
  Within 1 mo                                      10 270                                                           9/322 (2.8)                                           1.89 (0.99-3.64)
  2-12 mo                                          83 955                                                           53/322 (16.5)                                         1.66 (1.27-2.17)
  13 mo to 5 y                                     245 101                                                          94/322 (29.2)                                         1.22 (0.99-1.49)
  \>5 y                                            373 244                                                          166/322 (51.6)                                        1.96 (1.69-2.29)
  **Corpus and Uterus, Not Otherwise Specified**                                                                                                                          
  Within 1 mo                                      20 250                                                           19/1195 (1.6)                                         2.29 (1.46-3.59)
  2-12 mo                                          185 812                                                          75/1195 (6.3)                                         1.03 (0.82-1.29)
  13 mo to 5 y                                     677 783                                                          211/1195 (17.7)                                       0.88 (0.77-1.01)
  \>5 y                                            1 299 498                                                        890/1195 (74.5)                                       2.52 (2.36-2.69)

Abbreviations: NA, not applicable; SMR, standardized mortality ratio.

Analysis was limited to tumor sites for which at least 100 000 person-years were accrued.

For a certain time interval after diagnosis, the follow-up time of patients was calculated as the beginning of the interval to death from unintentional injury, death from other causes, or exit from the study or the end of the interval; the accrued person-years was then a summation of the follow-up time of all patients. Calculating the person-years of the 1-to 5-year interval, and the accrued person-years were then a summation of the follow-up time of all patients.

Reference population was defined as the general US population, 1973 to 2015. The SMRs were estimated as the ratios of observed to expected number of deaths. The observed deaths represent the total number of deaths from unintentional injury among patients with cancer recorded during the study period. The expected number of deaths represents the number of individuals who died of unintentional injury in the general population with a similar distribution of age at diagnosis (5-year intervals), sex, race/ethnicity (white, black, and other), and calendar year of diagnosis (5-year age intervals).

Discussion {#H1-4-ZOI190815}
==========

In this study, we comprehensively analyzed death from unintentional injury among more than 8.2 million patients with cancer using nationally representative data from the SEER program. We found that the incidence of death from unintentional injury among patients from the United States who had cancer was approximately 60% higher than that in the general US population, and we identified types of cancer and groups of patients with a higher incidence of death from unintentional injury.

Patients diagnosed with cancer often experience psychologic stress,^[@zoi190815r15],[@zoi190815r16]^ physical illnesses or disabilities,^[@zoi190815r17]^ social dysfunction,^[@zoi190815r18]^ substance abuse,^[@zoi190815r19]^ and poor quality of life,^[@zoi190815r20]^ all of which may be associated with an increased risk of death from unintentional injury. The results of the present study showed that patients with nearly all types of cancers were at an increased risk of death from unintentional injury. Of note, we found that patients with cancers of the liver, larynx, and esophagus had the highest rates of death from unintentional injury. These cancers are associated with alcohol consumption.^[@zoi190815r21]^ Patients with cancers associated with alcohol consumption may be at a higher risk of unintentional injuries.^[@zoi190815r22],[@zoi190815r23]^ The reasons for the association of these cancers with increased rate of death from unintentional injury warrant further investigation. In addition, brain cancer was identified as another type of cancer that was associated with a high rate of death from unintentional injury. Possible hypotheses to explain this association include physical disability,^[@zoi190815r24]^ cognitive dysfunction,^[@zoi190815r25]^ mental distress,^[@zoi190815r26]^ and epilepsy^[@zoi190815r27]^ in patients with brain cancer.

We observed that the risk of death from unintentional injury in patients with cancer was the highest immediately after diagnosis. Similarly, Yamauchi et al^[@zoi190815r8]^ reported a relative risk of 18.8 within the first year after cancer diagnosis and a sharply decreased relative risk of 1.2 beyond the first year after diagnosis in a population-based study in Japan. These findings highlight the concept that the diagnosis of cancer might be a major stressor that immediately affects the risk of fatal outcomes.^[@zoi190815r28]^

Older age was associated with higher rate of death from unintentional injury in our analysis. Older patients are more likely to have inattention, slow reaction, impaired vision or hearing, advanced disease, and other medical complications, all of which are associated with an increased risk of unintentional injuries, including falls and traffic accidents. Our study also showed that race/ethnicity may be significantly associated with the risk of death from unintentional injury. Patients of the American Indian or Alaskan Native population had the highest rates of death from unintentional injury compared with other races/ethnicities. This racial difference, which is consistent with that noted in the general American population by the National Center for Health Statistics,^[@zoi190815r29]^ may be associated with multiple risk factors, including behaviors, policies, and certain socioeconomic factors. Male sex and advanced stage of cancer were associated with a higher incidence of death from unintentional injury, which was similar to the results of a previous study.^[@zoi190815r30]^ In addition, our study showed that patients with cancer who were unmarried were more likely to have increased mortality due to unintentional injury. Furthermore, emotional support from a partner has been associated with decreased risk of death from unintentional injury.^[@zoi190815r31]^

Most patients with cancer now die of noncancer causes.^[@zoi190815r32]^ Our data suggest that death due to unintentional injury in cancer deserves further attention. Although some unintentional injuries are not completely preventable, our results showed that patients with cancer are at an increased risk of death due to unintentional injury, providing evidence for physicians, allied health professionals, and others to formulate plans for ways to prevent death from unintentional injury in this population. Further research is warranted to identify specific risk factors for the different categories of death from unintentional injury.

Limitations {#H2-8-ZOI190815}
-----------

This study has limitations. First, deaths from unintentional injury constitute a group of fatal events that are qualitatively different (eTable in the [Supplement](#note-ZOI190815-1-s){ref-type="supplementary-material"}). For instance, accidental poisonings by narcotic substances are likely to be associated with illicit drug use or addiction, distinguishing this group from other causes of death from unintentional injury.^[@zoi190815r33]^ However, SEER does not specify the precise cause of death from unintentional injury, and we were unable to focus on specific categories of death from unintentional injury among patients with cancer. In addition, the inclusion of sequelae of unintentional injuries (*ICD-10* codes Y85-Y86) may not be appropriate because these events can occur before cancer diagnosis. In our study, death from unintentional injury was analyzed as a whole.

Second, the risk of reporting bias in death certificates may lead to misclassification of causes of death.^[@zoi190815r34],[@zoi190815r35]^ Thus, it is difficult to distinguish between death from unintentional injury due to suicide and homicide.^[@zoi190815r6],[@zoi190815r36]^ For instance, poisonings are easily misclassified as unintentional injuries instead of suicides.^[@zoi190815r37],[@zoi190815r38]^ Because the literature pertaining to the misclassification of the cause of death is limited, we were unable to account for this confounding factor. Nevertheless, systematic and standardized data collection procedures are used to ensure that the causes of death recoded in SEER are accurate^[@zoi190815r39]^; thus, we believe that the present study presents a reliable picture of death from unintentional injury among patients with cancer in the United States.

Third, data on comorbidities, psychiatric conditions, performance status, quality of life, employment status, social support, dependence on alcohol, tobacco consumption, and other forms of substance abuse are unavailable in SEER; thus, we could not assess the possibility of an association of these factors with the risk of death from unintentional injury. Analyzing the extensive amount of available data from the SEER database remains a powerful, useful, and integral tool in medical research for the purpose of exploratory analyses.^[@zoi190815r35]^

Conclusions {#H1-5-ZOI190815}
===========

These findings suggest for the first time, to our knowledge, that the incidence of death from unintentional injury among patients with cancer is significantly higher than that in the general population in the United States. Clinicians at all levels of health care should be aware of the potential for death from unintentional injury among patients with cancer and its associated risk factors. Our results suggest the need for targeted preventive interventions of unintentional injuries among patients with cancer.

###### 

**eTable.** Detailed *ICD* Codes of Death From Unintentional Injury (Accidents and Adverse Effects)

###### 

Click here for additional data file.
